XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
May 01, 2020
Accounting Policies [Line Items]        
Accumulated other comprehensive loss $ (40,141) $ (67,187) $ (47,128)  
Retained earnings 385,972 515,869 414,138  
Other income, net 27,397 13,170    
(Loss) income before income taxes (15,376) 4,421    
Net loss 24,741 4,960    
Net Income (Loss) Attributable to Parent $ (25,441) $ (6,698)    
Basic and diluted net loss per share attributable to Cimpress plc $ (0.97) $ (0.26)    
Diluted net loss per share attributable to Cimpress plc   $ (0.26)    
Foreign currency translation losses, net of hedges $ (8,182) $ (183)    
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent (6,835) 674    
Effect of exchange rate changes on monetary assets and liabilities denominated in non-functional currency (749) 174    
Revenue 703,415 657,599    
Cost of revenue (1) 377,735 338,989    
Finance Lease, Principal Payments 2,412 2,526    
Proceeds from the sale of assets 122 1,699    
Marketable Securities, Current 101,726   49,952  
Marketable securities, non-current 22,449   0  
Total Marketable Securities 124,175   49,952  
Unrealized Loss on Securities (1,174)      
Investments, Fair Value Disclosure 123,001   49,406  
Unrealized Gain (Loss) on Investments   (546)    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 28,645 13,327    
Foreign Currency Transaction Gain (Loss), Realized (197) 323    
Other Nonoperating Gains (Losses) (1,051) (480)    
Other Nonoperating Income (Expense) 27,397 13,170    
Realized gain (loss) on derivatives not designated as hedging instruments 14,621 3,672    
Unrealized gain on derivatives not designated as hedging instruments included in net loss $ 14,024 $ 16,534    
Weighted average shares outstanding — basic and diluted 26,178,818 26,072,249    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,688,813 530,011    
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 60
Certain impairments and other adjustments $ 3,456 $ 780    
Previously Reported [Member]        
Accounting Policies [Line Items]        
Accumulated other comprehensive loss   (83,732)    
Retained earnings   532,414    
Other income, net   22,197    
(Loss) income before income taxes   13,448    
Net loss   (4,067)    
Net Income (Loss) Attributable to Parent   $ 2,329    
Basic and diluted net loss per share attributable to Cimpress plc   $ 0.09    
Diluted net loss per share attributable to Cimpress plc   $ 0.09    
Foreign currency translation losses, net of hedges   $ (9,210)    
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent   (8,353)    
Effect of exchange rate changes on monetary assets and liabilities denominated in non-functional currency   8,853    
Other Nonoperating Income (Expense)   22,197    
Revision of Prior Period, Error Correction, Adjustment [Member]        
Accounting Policies [Line Items]        
Accumulated other comprehensive loss   16,545    
Retained earnings   (16,545)    
Other income, net   9,027    
(Loss) income before income taxes   (9,027)    
Net loss   9,027    
Net Income (Loss) Attributable to Parent   $ (9,027)    
Basic and diluted net loss per share attributable to Cimpress plc   $ (0.35)    
Diluted net loss per share attributable to Cimpress plc   $ (0.35)    
Foreign currency translation losses, net of hedges   $ 9,027    
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent   9,027    
Effect of exchange rate changes on monetary assets and liabilities denominated in non-functional currency   (9,027)    
Other Nonoperating Income (Expense)   $ 9,027    
Commercial Paper        
Accounting Policies [Line Items]        
Marketable Securities, Current 50,608      
Unrealized Loss on Securities (261)      
Investments, Fair Value Disclosure 50,347      
Corporate Debt Securities        
Accounting Policies [Line Items]        
Marketable Securities, Current 51,118   49,952  
Marketable securities, non-current 13,239      
US Government Debt Securities [Member]        
Accounting Policies [Line Items]        
Marketable securities, non-current $ 9,210      
Warrant [Member]        
Accounting Policies [Line Items]        
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 1,055,377 409,561    
Foreign Exchange Forward [Member]        
Accounting Policies [Line Items]        
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net $ 28,645 $ 12,863    
Currency Swap [Member]        
Accounting Policies [Line Items]        
Accumulated other comprehensive loss 15,079      
Interest Rate Swap [Member]        
Accounting Policies [Line Items]        
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 0 464    
Marketable securities, current [Member]        
Accounting Policies [Line Items]        
Unrealized Loss on Securities 779      
Investments, Fair Value Disclosure 100,947      
Marketable securities, current [Member] | Corporate Debt Securities        
Accounting Policies [Line Items]        
Unrealized Loss on Securities 518 $ 546    
Investments, Fair Value Disclosure 50,600   $ 49,406  
Marketable securities, noncurrent [Member] | Corporate Debt Securities        
Accounting Policies [Line Items]        
Unrealized Loss on Securities 271      
Investments, Fair Value Disclosure 12,968      
Marketable securities, noncurrent [Member] | US Government Debt Securities [Member]        
Accounting Policies [Line Items]        
Unrealized Loss on Securities 124      
Investments, Fair Value Disclosure $ 9,086